These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4374651)

  • 1. [Conjugated estrogens as a hemostatic in urology with special reference to their intramuscular administration].
    Altieri A; Romano C
    Minerva Urol; 1972; 24(6):286-95. PubMed ID: 4374651
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventive treatment of thromboembolic postoperative complications in urology using subcutaneous calcium heparinate].
    Xerri A; Deburge JP; Aubert J; Weisgerber G
    J Urol Nephrol (Paris); 1974 Mar; 80(3):283-90. PubMed ID: 4137454
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemostatic action of estrogens in ORL. Trials of Premarine].
    Hadj-Djilani A
    Rev Med Suisse Romande; 1966 Mar; 86(3):216-24. PubMed ID: 4286236
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of conjugated oestrogens (Premarin) on blood loss during periodontal surgery.
    van Heerden JD; Dreyer WP; van der Bijl P
    J Dent Assoc S Afr; 1986 Oct; 41(10):701-4. PubMed ID: 3035758
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
    Winkler UH; Krämer R; Kwee B; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural oestrogen replacement therapy and blood clotting.
    Poller L
    Postgrad Med J; 1976; 52 Suppl 6():28-9. PubMed ID: 185605
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hemostatic system in urology patients before and after surgery].
    Panchenko VM; Tsitron AO; Burkovskiĭ MIu
    Sov Med; 1981; (7):27-31. PubMed ID: 7292122
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemostatic effect of conjugated estrogenic substances].
    Toriyama M; Hoshino T; Sato Y
    Jibiinkoka; 1967 Mar; 39(3):333-6. PubMed ID: 4294843
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of Ketalar in urology].
    Ishida G; Ikeda Y; Wataru S; Takenaka I
    Hinyokika Kiyo; 1971 Sep; 17(9):588-91. PubMed ID: 5166129
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estrogens in ophthalmology. Experimental studies].
    Avedikian H
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1968; 175(2):174-80. PubMed ID: 4299044
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the administration of liver extract after surgical operations in urology].
    Kondoh K; Imaide Y; Uchida M; Watanabe H
    Hinyokika Kiyo; 1986 Jan; 32(1):163-7. PubMed ID: 3962806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proliferation dosage and threshold dosage of conjugated estrogens].
    Kraus H; Heinen G; Mootz M
    Geburtshilfe Frauenheilkd; 1971 Jul; 31(7):669-77. PubMed ID: 4327502
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous, intramuscular and macrocrystal sodium nitrofurantoin in the postoperative period in urology].
    Sánchez Sañudo L; Rebaudi AS; Militello I
    Rev Argent Urol Nefrol; 1969; 38(1):111. PubMed ID: 5379738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with the hemostyptic Presomen].
    Volkmuth G
    HNO; 1967 Apr; 15(4):123-4. PubMed ID: 4298614
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
    Lobo RA; Pickar JH; Wild RA; Walsh B; Hirvonen E
    Obstet Gynecol; 1994 Dec; 84(6):987-95. PubMed ID: 7970483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual effects of estrogens on blood clotting time.
    Mandoki JJ; Zavala E; Silva G; Mendoza-Patiño N; Rubio-Póo C; Medina-Martínez S; Domínguez-Escoto P
    Proc West Pharmacol Soc; 1983; 26():45-8. PubMed ID: 6310634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of premarin in ORL].
    Mounier-Kuhn P; Bouchayer M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1970 Oct; 19(8):693-6. PubMed ID: 4321287
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemostatic effect of "coagumin" in clinical use].
    Kuze M; Kashiwagi T; Okita J; Komiya T; Nihira H
    Hinyokika Kiyo; 1966 Jun; 12(6):576-82. PubMed ID: 6006918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.